Rankings
▼
Calendar
EYPT Q3 2023 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$15M
+51.8% YoY
Gross Profit
$14M
92.1% margin
Operating Income
-$14M
-94.7% margin
Net Income
-$13M
-83.0% margin
EPS (Diluted)
$-0.33
QoQ Revenue Growth
+67.0%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$17M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$160M
Total Liabilities
$101M
Stockholders' Equity
$59M
Cash & Equivalents
$133M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$15M
$10M
+51.8%
Gross Profit
$14M
$9M
+62.7%
Operating Income
-$14M
-$18M
+21.7%
Net Income
-$13M
-$18M
+31.5%
Revenue Segments
License And Collaboration Agreement
$14M
93%
Product
$816,000
5%
Royalty
$249,000
2%
← FY 2023
All Quarters
Q4 2023 →